CarolynAFelixMD
Pediatric Hematology & Oncology • Philadelphia, PAProfessor of Pediatrics, University Pennsylvania
Dr. Felix is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Oncology
Philadelphia, PA 19104Phone+1 215-590-3535Fax+1 215-590-3992
Education & Training
National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1984 - 1987
UPMC Medical EducationResidency, Pediatrics, 1981 - 1984
Boston University School of MedicineClass of 1981
Certifications & Licensure
PA State Medical License 1982 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Philadelphia Magazine Castle Connolly, 2005-2006, 2009-2012
- Join now to see all
Clinical Trials
- DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 1997 Jan 01
- Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 75 citationsTherapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.Jolanta Libura, Diana J. Slater, Carolyn A. Felix, Christine Richardson
Blood. 2005-03-01 - 134 citationsTopoisomerase II and leukemiaMaryJean Pendleton, R. Hunter Lindsey, Carolyn A. Felix, David Grimwade, Neil Osheroff
Annals of the New York Academy of Sciences. 2014-03-01 - 834 citationsHaploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaW.-J. Song, M. G. Sullivan, R. D. Legare, S Hutchings, Xiaolian Tan
Nature Genetics. 1999-10-01
Journal Articles
- Targeting EIF4E Signaling with Ribavirin in Infant Acute Lymphoblastic LeukemiaNyla A Heerema, James W Davenport, Carolyn A Felix, Andrew J Carroll, ZoAnn E Dreyer, Alix E Seif, David T Teachey, Joanne M Hilden, Sarah K Tasian, Cheryl L Willman, ..., Nature
Press Mentions
The Leukemia & Lymphoma Society (LLS) Fuels the Next Generation of Cancer Research Committing More Than $188 Million in FundingNovember 8th, 2018
Grant Support
- MLL In Hematopoiesis And Leukemia In The Zebrafish ModelNational Cancer Institute2010–2012
- Antineoplastic V Leukemogenic Epipodophyllotoxin EffectsNational Cancer Institute2004–2007
- Molecular Genetic Changes In Leukemia In InfantsNational Cancer Institute2004–2006
- Biomarkers Of Treatment Related LeukemiaNational Cancer Institute2004
- Biomarkers Of Treatment Related LeukemiaNational Cancer Institute2000–2003
- Molecular Genetic Changes In Leukemia In InfantsNational Cancer Institute1999–2003
- Antineoplastic V Leukemogenic Epipodophyllotoxin EffectsNational Cancer Institute1999–2003
- Antineoplastic VS Leukemogenic Epipodophyllotoxin EffectsNational Center For Research Resources2000–2002
- Epipodophyllotoxin Associated Secondary LeukemiaNational Cancer Institute1995–1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
